CytoSorbents Corporation (CTSO)

[andy55q]

• 27.01.2016 The successful use of cytokines Cytosorb adsorber in conjunction with ECMO in the treatment of swine flu, and the treatment of acute sepsis.
The Journal "Critical Care Medicine" published the results of the use of innovative adsorption system cytokines Cytosorb in conjunction with ECMO for treatment of swine flu (influenza A virus (H1N1)), treatment of severe sepsis complicated by cardiogenic shock and acute respiratory distress syndrome. This combinatorial technique showed superior results. Powered by a clinical case report demonstrates the successful use of ECMO and the adsorption of cytokines for the treatment of severe sepsis caused by PVL-S.aureus, complicated with acute respiratory distress syndrome and cardiomyopathy, and suggests that the adsorption of cytokines is convincing more adequate treatment of acute sepsis and helps prevent multiple organ failure. adsorption system cytokines (inflammatory mediators) Cytosorb is an innovative product for the treatment of sepsis and septic shock and is available from February 2016 in the Russian market. The company is the exclusive distributor Intensivmed Cytosorbents in the Russian Federation.